Scientists from National Chemical Laboratory and the International Centre for Genetic Engineering and Biotechnology (ICGEB) have achieved a potential breakthrough in anti-malarial research. Three research groups, each led by NCL’s D Srinivasa Reddy and Dhanasekaran Shanmugam, and Amit Sharma of ICGEB, have identified fungal-metabolite molecules as a potential anti-malarial drug.